Zobrazeno 1 - 10
of 68
pro vyhledávání: '"N. Chrestian"'
Publikováno v:
Neuromuscular Disorders. 32:S48
Autor:
L. Vogt, A. Marefi, K. Amburgey, N. Addour, E. Widjaja, C. Poulin, M. Oskoui, H. McMillan, N. Chrestian, C. Saint-Martin, M. Srour, J. Dowling
Publikováno v:
Neuromuscular Disorders. 32:S46
Autor:
D Pellerin, A Aykanat, B Ellezam, EC Troiano, J Karamchandani, M Dicaire, M Petitclerc, R Robertson, X Allard-Chamard, D Brunet, CG Konersman, J Mathieu, J Warman Chardon, VA Gupta, AH Beggs, B Brais, N Chrestian
Publikováno v:
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 49:S3-S3
Background: Mutations in the slow skeletal muscle troponin T (TNNT1) gene cause a congenital nemaline myopathy resulting in death from respiratory insufficiency in early infancy. We report on four French Canadians with a novel congenital TNNT1 myopat
Autor:
D Pellerin, A Aykanat, B Ellezam, EC Troiano, J Karamchandani, M Dicaire, M Petitclerc, R Robertson, X Allard-Chamard, D Brunet, CG Konersman, J Mathieu, J Warman Chardon, VA Gupta, AH Beggs, B Brais, N Chrestian
Publikováno v:
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 48:S14-S15
Background: Mutations in the slow skeletal muscle troponin T (TNNT1) gene cause a congenital nemaline myopathy resulting in death from respiratory insufficiency in early infancy. We report on four French Canadians with a novel congenital TNNT1 myopat
Publikováno v:
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 48:S57-S57
Background: Nusinersen is approved for spinal muscular amyotrophy type I,II,III and is available for adult and pediatric populations since January 2019 at the CHU de Québec-UL. Methods: Patients who received at least one dose of nusinersen between J
Publikováno v:
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 48:S47-S47
Background: Hormonal therapy is a standard treatment for infantile spasms. The high doses given and long treatment duration expose patients to the risk of adrenal insufficiency (AI). This study aims to quantify the incidence of AI among children with
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Neuromuscular Disorders. 30:S133
Autor:
D Pellerin, A Aykanat, B Ellezam, J Karamchandani, J Mathieu, J Warman Chardon, CG Konersman, AH Beggs, B Brais, N Chrestian
Publikováno v:
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 46:S21
Background: Mutations of the slow skeletal muscle troponin-T1 (TNNT1) gene are a rare cause of nemaline myopathy. The phenotype is characterized by severe amyotrophy and contractures. Death from respiratory insufficiency occurs in infancy. We report
Publikováno v:
Neuromuscular Disorders. 28:S48